1.Factors Influencing Depression in Patients with Chronic Renal Failure.
Jeongyee BAE ; Hyunjoo PARK ; Songsoon KIM ; Jisoo BANG
Journal of Korean Academy of Psychiatric and Mental Health Nursing 2011;20(3):261-270
PURPOSE: Objectives of this study were to identify factors influencing depression in patients with chronic renal failure according to patient characteristics and to provide basic data to develop nursing interventions for depression in these patients. METHODS: This descriptive correlative study was conducted using structured questionnaires with 114 patients diagnosed with chronic renal failure. Data were analyzed using t-tests, ANOVA, Pearson's correlation and multiple regression analysis with SPSS/WIN 18.0. RESULTS: 1) Level of depression was different according to the history of smoking (p<.001), past health history (p=.001), only drugs as therapy, peritoneal dialysis, hemodialysis (p=.028), and perceived health status (p<.001); 2) Significant correlations were found between depression, stress, value of life and social support; 3) multiple regression analysis showed that stress (beta=.24, t=3.41, p=.001), value of life (beta=-.46, t=-6.37, p<.001) and social support (beta=-.19, t=-2.79, p=.006) in that order contributed to depression and explained 56.4% of variance in depression. CONCLUSION: Findings from this study indicate that health professionals should provide proper management for depression for patients with chronic renal failure, as well as factors influencing depression, including stress, value of life and social support. There is also a need to implement stress management and self-help group programs for these patients.
Depression*
;
Health Occupations
;
Humans
;
Kidney Failure, Chronic*
;
Nursing
;
Peritoneal Dialysis
;
Surveys and Questionnaires
;
Renal Dialysis
;
Self-Help Groups
;
Smoke
;
Smoking
;
Value of Life
2.Impact of Childbearing Decisions on Family Size of Korean Women with Systemic Lupus Erythematosus.
In Je KIM ; Hyoun Ah KIM ; Chang Hee SUH ; Yong Wook PARK ; Hye Soon LEE ; So Young BANG ; Sang Cheol BAE ; Young Mo KANG ; Won Kyung LEE ; Hyesook PARK ; Jisoo LEE
Journal of Korean Medical Science 2016;31(5):729-734
Systemic lupus erythematosus (SLE) predominantly affects women in their reproductive years and has a significant impact on childbearing. We investigated the influence of personal decision on family size among Korean women with SLE and factors that affect the decisions. A case-control study comparing childbearing history and decisions of 112 SLE patients and 135 controls was performed. Women with SLE participating in the Network for Lupus Clinical Research in South Korea and matching controls between ages of 18-45, who are/were married or living with a partner were included. Data regarding socio-demographics, reproductive history, and childbearing decisions were collected through a survey using a standardized questionnaire and medical record review. More women with SLE reported at least one pregnancy (85.7% vs. 71.9%, P = 0.009) or at least one live birth (85.7% vs. 71.9%, P = 0.003) compared with controls. Mean number of pregnancies was significantly higher (2.4 ± 1.6 vs. 1.4 ± 1.3, P < 0.001), and mean number of live births was significantly lower in women with SLE (1.2 ± 0.8 vs. 1.6 ± 0.8, P < 0.001). Significantly more women with SLE made the decision not to have children compared with controls (54.5% vs. 40.7%, P = 0.031), and health-related concerns were the major cause of the decision. Other socio-demographic factors did not influence the decision to limit childbearing in SLE women. The disease-related concerns had significant impact on family size and childbearing decisions among Korean women with SLE.
Adolescent
;
Adult
;
Asian Continental Ancestry Group
;
Case-Control Studies
;
Demography
;
Family Characteristics
;
Female
;
Humans
;
Live Birth
;
Lupus Erythematosus, Systemic/*pathology/psychology
;
Odds Ratio
;
Pregnancy
;
Pregnancy Complications
;
Reproductive Behavior/*psychology
;
Republic of Korea
;
Surveys and Questionnaires
;
Tertiary Care Centers
;
Young Adult
3.Prevalence and Associated Factors for Non-adherence in Patients with Rheumatoid Arthritis
Dam KIM ; Ji Young CHOI ; Soo Kyung CHO ; Chan Bum CHOI ; So Young BANG ; Hoon Suk CHA ; Jung Yoon CHOE ; Won Tae CHUNG ; Seung Jae HONG ; Tae Hwan KIM ; Tae Jong KIM ; Eunmi KOH ; Hye Soon LEE ; Jisoo LEE ; Shin Seok LEE ; Sung Won LEE ; Sung Hoon PARK ; Seung Cheol SHIM ; Dae Hyun YOO ; Bo Young YOON ; Sang Cheol BAE ; Yoon Kyoung SUNG
Journal of Rheumatic Diseases 2018;25(1):47-57
OBJECTIVE: To estimate the prevalence of non-adherence to rheumatoid arthritis (RA) medication and identify the associated factors for non-adherence in RA patients. METHODS: Among the KORean Observational study Network for Arthritis 3,523 patients who completed a questionnaire about the adherence to RA medication were analyzed. The patients were divided into two groups: 1) adherent group, patients who skipped medication ≤5 days within the past 2 months; and 2) non-adherent group, patients who skipped ≥6 days of medication. The baseline characteristics were compared, and multivariable regression analysis was performed to identify the associated factors for non-adherence. RESULTS: The non-adherent group had 339 patients (9.6%). The common causes of non-adherence were forgetfulness (45.8%), absence of RA symptoms (24.7%), and discomfort with RA medication (13.1%). Younger age (odds ratio [OR] 1.02, p < 0.01) and higher income (OR 1.70, p < 0.01) were associated with an increased risk of non-adherence. Whereas higher functional disability (OR 0.68, p < 0.01) and oral corticosteroid use (OR 0.73, p=0.02) were associated with a decreased risk of non-adherence. The associated factors differed according to cause of non-adherence. Having adverse events (OR 2.65, p=0.02) was associated with the risk of non-adherence due to discomfort with RA medication while a higher level of education (OR 2.37, p=0.03) was associated with the risk of non-adherence due to an absence of RA symptoms. CONCLUSION: The 9.6% of Korean RA patients were non-adherent to RA medication. The associated factors differed according to the cause of non-adherence. Therefore, an individualized approach will be needed to improve the adherence to RA medication.
Arthritis
;
Arthritis, Rheumatoid
;
Education
;
Humans
;
Medication Adherence
;
Observational Study
;
Prevalence
4.Prediction for TNF Inhibitor Users in RA Patients According to Reimbursement Criteria Based on DAS28.
Soyoung WON ; Yoon Kyoung SUNG ; Soo Kyung CHO ; Chan Bum CHOI ; Eun Mi KOH ; Seong Kyu KIM ; Jinseok KIM ; Tae Hwan KIM ; Hyoun Ah KIM ; Seong Su NAH ; So Young BANG ; Chang Hee SUH ; Seung Cheol SHIM ; Dae Hyun YOO ; Bo Young YOON ; Sang Hoon LEE ; Sung Won LEE ; Shin Seok LEE ; Yeon Ah LEE ; Jaejoon LEE ; Jisoo LEE ; Hye Soon LEE ; Mi Kyoung LIM ; Jae Bum JUN ; Chan Hong JEON ; Young Ok JUNG ; Won Tae CHUNG ; Hoon Suk CHA ; Jung Yoon CHOE ; Seung Jae HONG ; Sang Cheol BAE
Journal of Rheumatic Diseases 2014;21(2):64-73
OBJECTIVE: The purpose of this study is to examine the difference between the numbers of patients in rheumatoid arthritis (RA) who are eligible to TNF inhibitors by the past Korean National Health Insurance reimbursement guideline and by the disease activity score with 28-joint assessment (DAS28) based criteria. METHODS: Data were obtained from a multi-center registry for biologics users in Korean RA patients, BIOlogics Pharmacoepidemiologic StudY (BIOPSY). DAS28 was calculated based on either ESR or CRP, and DAS28 of more than 5.1 or between 3.2 and 5.1 with radiographic changes was defined as a cut-off point for the initiation of TNF inhibitors. For the maintenance criteria, we used both of improving in DAS28 score (>1.2) and low disease activity (DAS 28<3.2). Differences between the numbers in each step by two criteria were described with Chi-square test and Kappa agreement. RESULTS: Of the 489 patients in BIOPSY, 299 were included in this study. Among them, 278 patients (93.0%) were eligible of TNF inhibitors when we applied the new initiation criteria with DAS28-ESR, and 244 patients (81.6%) were indicated for TNF inhibitors with DAS28-CRP. For the maintenance criteria, a low disease activity (DAS28<3.2) in 3 months after starting TNF inhibitors is too strict for achieving (33.6% with DAS28-ESR and 50.0% with DAS28-CRP). Instead, decreasing DAS28 by more than 1.2 is more reasonable as a tool for deciding early responsiveness of TNF inhibitors in RA patients (81.2% both with DAS28-ESR and DAS28-CRP). CONCLUSION: Our results show that the candidates for TNF inhibitors will be enormously changed according to a change in the reimbursement criteria. To define appropriate patients to receive TNF inhibitors, a further study with regard to the impact of changes in the reimbursement criteria on the outcomes of RA patients will be required.
Arthritis, Rheumatoid
;
Biological Products
;
Biopsy
;
Humans
;
National Health Programs
5.Impact of early diagnosis on functional disability in rheumatoid arthritis.
Dam KIM ; Chan Bum CHOI ; Jiyoung LEE ; Soo Kyung CHO ; Soyoung WON ; So Young BANG ; Hoon Suk CHA ; Jung Yoon CHOE ; Won Tae CHUNG ; Seung Jae HONG ; Jae Bum JUN ; Young Ok JUNG ; Jinseok KIM ; Seong Kyu KIM ; Tae Hwan KIM ; Tae Jong KIM ; Eunmi KOH ; Hye Soon LEE ; Jaejoon LEE ; Jisoo LEE ; Sang Heon LEE ; Shin Seok LEE ; Sung Won LEE ; Seung Cheol SHIM ; Dae Hyun YOO ; Bo Young YOON ; Yoon Kyoung SUNG ; Sang Cheol BAE
The Korean Journal of Internal Medicine 2017;32(4):738-746
BACKGROUND/AIMS: To determine whether early diagnosis is beneficial for functional status of various disease durations in rheumatoid arthritis (RA) patients. METHODS: A total of 4,540 RA patients were enrolled as part of the Korean Observational Study Network for Arthritis (KORONA). We defined early diagnosis as a lag time between symptom onset and RA diagnosis of ≤ 12 months, whereas patients with a longer lag time comprised the delayed diagnosis group. Demographic characteristics and outcomes were compared between early and delayed diagnosis groups. Logistic regression analyses were performed to identify the impact of early diagnosis on the development of functional disability in RA patients. RESULTS: A total of 2,597 patients (57.2%) were included in the early diagnosis group. The average Health Assessment Questionnaire-Disability Index (HAQ-DI) score was higher in the delayed diagnosis group (0.64 ± 0.63 vs. 0.70 ± 0.66, p < 0.01), and the proportion of patients with no functional disability (HAQ = 0) was higher in the early diagnosis group (22.9% vs. 20.0%, p = 0.02). In multivariable analyses, early diagnosis was independently associated with no functional disability (odds ratio [OR], 1.19; 95% confidence interval [CI], 1.01 to 1.40). In a subgroup analysis according to disease duration, early diagnosis was associated with no functional disability in patients with disease duration < 5 years (OR, 1.37; 95% CI, 1.09 to 1.72) but not in patients with longer disease duration (for 5 to 10 years: OR, 1.07; 95% CI, 0.75 to 1.52; for ≥ 10 years: OR, 0.92; 95% CI, 0.65 to 1.28). CONCLUSIONS: Early diagnosis is associated with no functional disability, especially in patients with shorter disease duration.
Arthritis
;
Arthritis, Rheumatoid*
;
Delayed Diagnosis
;
Diagnosis
;
Early Diagnosis*
;
Humans
;
Logistic Models
;
Observational Study